NCT05919108 2025-09-09Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast CancersVanderbilt-Ingram Cancer CenterPhase 2 Recruiting30 enrolled
NCT06067503 2025-04-22Biomarkers to Detect Endocrine Therapy ResistanceUniversity of Wisconsin, MadisonPhase 2 Recruiting8 enrolled